Behind the paper
Share the real story behind your paper, from conception to publication, the highs and the lows.
A battle between human and HIV revealed by proteomics
When bacteria hijack cellular communication systems.
Dampened inflammation in bats: The NLRP3 inflammasome.
Contributor
Nature Comms
Towards more affordable pneumococcal vaccines
Check out how we are developing an alternative, streamlined method for manufacturing pneumococcal conjugate vaccines all within the lab safe, bacterium E. coli…
Contributor
Nature Comms
Immunotherapy against cancer to be used in HIV cure strategy: a proof-of-concept
In the era of suppressive antiretroviral therapy (ART), HIV reservoir cells are the last hurdle in eradicating the virus. Here, we are testing the hypothesis that immunotherapy against cancer potentiates the reactivation of latently infected cells isolated from ART-suppressed individuals favoring their elimination.
